Description
Tadalista Super Active 20 mg
Tadalista Super Active is a product name used for a tadalafil 20 mg softgel capsule. Tadalafil is a prescription phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction and, in some approved products, benign prostatic hyperplasia-related symptoms. The exact trade name itself is not verified here as an official regulatory product name, so the description below is based on the consistently supported active ingredient, tadalafil.
Active Ingredient and Medicine Class
The verified active ingredient is tadalafil. It belongs to the PDE5 inhibitor class. This group of medicines increases blood flow to erectile tissue by enhancing the natural nitric-oxide/cGMP pathway.
Established Medical Uses
Tadalafil is established for the treatment of erectile dysfunction. Official prescribing information also includes use for benign prostatic hyperplasia and, in some products, combined erectile dysfunction and BPH indications. The specific approved use depends on the product and local regulatory status.
How It Works
Tadalafil blocks PDE5, an enzyme that breaks down cyclic GMP. By slowing this breakdown, it helps relax smooth muscle and supports increased blood flow in response to sexual stimulation. It does not cause an erection by itself.
Important Safety Information
Tadalafil is contraindicated with nitrates and with guanylate cyclase stimulators such as riociguat because of the risk of a marked blood-pressure drop. It should also be used carefully in people with cardiovascular disease, low blood pressure, severe liver or kidney impairment, a history of vision loss related to non-arteritic anterior ischaemic optic neuropathy, or a history of prolonged erection.
Important interaction risks include alpha-blockers, antihypertensive medicines, strong CYP3A4 inhibitors such as ritonavir or ketoconazole, and other PDE5 inhibitors. Alcohol may increase the chance of blood-pressure-related adverse effects.
Possible Side Effects
Common adverse effects reported with tadalafil include headache, dyspepsia, back pain, muscle pain, nasal congestion, and flushing. More serious reactions can include priapism, sudden vision loss, sudden hearing loss, significant hypotension, and rare hypersensitivity reactions.
Scientific Evidence
Clinical reviews and meta-analyses support tadalafil as an effective oral PDE5 inhibitor for erectile dysfunction, with benefit across a range of severities and causes. Evidence also supports a longer therapeutic window than shorter-acting PDE5 inhibitors, which may allow more flexible timing of sexual activity. Reviews of daily versus on-demand use show both regimens can be effective, with differences that may be small and dependent on patient context.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet, prescribing information, or individual assessment by a qualified health professional.
Medical Sources
- U.S. Food and Drug Administration (FDA), Tadalafil tablets, full prescribing information
- Meuleman EJH et al., “Review of tadalafil in the treatment of erectile dysfunction,” Expert Opinion on Pharmacotherapy, 2003. PubMed article
